Is glutamate associated with fear extinction and cognitive behavior therapy outcome in OCD? A pilot study

[1]  A. Pozza,et al.  Drop-out and efficacy of group versus individual cognitive behavioural therapy: What works best for Obsessive-Compulsive Disorder? A systematic review and meta-analysis of direct comparisons , 2017, Psychiatry Research.

[2]  A. Wenzel.  Basic Strategies of Cognitive Behavioral Therapy. , 2017, The Psychiatric clinics of North America.

[3]  R. Marsh,et al.  Basolateral amygdala–ventromedial prefrontal cortex connectivity predicts cognitive behavioural therapy outcome in adults with obsessive–compulsive disorder , 2017, Journal of psychiatry & neuroscience : JPN.

[4]  B. Vervliet,et al.  Does fear extinction in the laboratory predict outcomes of exposure therapy? A treatment analog study. , 2017, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[5]  M. Tegenthoff,et al.  d-Cycloserine facilitates extinction learning and enhances extinction-related brain activation , 2017, Neurobiology of Learning and Memory.

[6]  Cheri A. Levinson,et al.  D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data , 2017, JAMA psychiatry.

[7]  S. Posse,et al.  Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial , 2017, Neuropsychopharmacology.

[8]  M. Paulus,et al.  Brain activation during fear extinction predicts exposure success , 2017, Depression and anxiety.

[9]  Jasper A. J. Smits,et al.  Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions , 2016, Biological Psychiatry.

[10]  R. Maddock,et al.  Acute Modulation of Cortical Glutamate and GABA Content by Physical Activity , 2016, The Journal of Neuroscience.

[11]  G. Kvale,et al.  Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. , 2015, Clinical psychology review.

[12]  D. Stein,et al.  Efficacy of cognitive-behavioral therapy for obsessive–compulsive disorder , 2015, Psychiatry Research.

[13]  Dan J Stein,et al.  Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. , 2015, The Cochrane database of systematic reviews.

[14]  Keith Matthews,et al.  Efficacy of cognitive-behavioral therapy for obsessive–compulsive disorder , 2015, Psychiatry Research.

[15]  Blake L. Rosenbaum,et al.  Neuroscience of fear extinction: implications for assessment and treatment of fear-based and anxiety related disorders. , 2014, Behaviour research and therapy.

[16]  E. Storch,et al.  Cognitive behavior therapy for obsessive-compulsive and related disorders. , 2014, The Psychiatric clinics of North America.

[17]  E. Coutinho,et al.  Does D-Cycloserine Enhance Exposure Therapy for Anxiety Disorders in Humans? A Meta-Analysis , 2014, PloS one.

[18]  P. Fitzgerald,et al.  Can fear extinction be enhanced? A review of pharmacological and behavioral findings , 2014, Brain Research Bulletin.

[19]  Saadallah Ramadan,et al.  Glutamate and glutamine: a review of in vivo MRS in the human brain , 2013, NMR in biomedicine.

[20]  J. Pujol,et al.  Brain regions related to fear extinction in obsessive-compulsive disorder and its relation to exposure therapy outcome: a morphometric study , 2013, Psychological Medicine.

[21]  M. Popoli,et al.  The Action of Antidepressants on the Glutamate System: Regulation of Glutamate Release and Glutamate Receptors , 2013, Biological Psychiatry.

[22]  S. Rauch,et al.  Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit. , 2013, JAMA psychiatry.

[23]  Joseph E LeDoux,et al.  Chronic Antidepressant Treatment Impairs the Acquisition of Fear Extinction , 2013, Biological Psychiatry.

[24]  Jamie D. Feusner,et al.  Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder. , 2013, Journal of psychiatric research.

[25]  D. Goff,et al.  Failure of neural responses to safety cues in schizophrenia. , 2012, Archives of general psychiatry.

[26]  Mark Slifstein,et al.  Investigation of Cortical Glutamate–Glutamine and γ-Aminobutyric Acid in Obsessive–Compulsive Disorder by Proton Magnetic Resonance Spectroscopy , 2012, Neuropsychopharmacology.

[27]  L. Drummond,et al.  Community treatment of severe, refractory obsessive-compulsive disorder. , 2012, Behaviour research and therapy.

[28]  J. Castro-Fornieles,et al.  Proton magnetic resonance spectroscopy in pediatric obsessive–compulsive disorder: Longitudinal study before and after treatment , 2012, Psychiatry Research: Neuroimaging.

[29]  N. Salamon,et al.  MRSI correlates of cognitive–behavioral therapy in pediatric obsessive–compulsive disorder , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[30]  Mohammed R. Milad,et al.  The study of fear extinction: implications for anxiety disorders. , 2011, The American journal of psychiatry.

[31]  Michael Davis,et al.  NMDA receptors and fear extinction: implications for cognitive behavioral therapy , 2011, Dialogues in clinical neuroscience.

[32]  S. A. Wijtenburg,et al.  Very short echo time improves the precision of glutamate detection at 3T in 1H magnetic resonance spectroscopy , 2011, Journal of magnetic resonance imaging : JMRI.

[33]  S. Chantal,et al.  Brain magnetic resonance spectroscopy in obsessive–compulsive disorder: The importance of considering subclinical symptoms of anxiety and depression , 2011, Psychiatry Research: Neuroimaging.

[34]  I. Pavlov,et al.  Conditioned reflexes: An investigation of the physiological activity of the cerebral cortex , 2010, Annals of Neurosciences.

[35]  Jasper A. J. Smits,et al.  Extinction retention predicts improvement in social anxiety symptoms following exposure therapy , 2009, Depression and anxiety.

[36]  B. Harrison,et al.  Anterior Cingulate Glutamate–Glutamine Levels Predict Symptom Severity in Women With Obsessive–Compulsive Disorder , 2008, The Australian and New Zealand journal of psychiatry.

[37]  B. Fallone,et al.  Exploiting the chemical shift displacement effect in the detection of glutamate and glutamine (Glx) with PRESS. , 2008, Journal of magnetic resonance.

[38]  René Garcia,et al.  Time course of extracellular catecholamine and glutamate levels in the rat medial prefrontal cortex during and after extinction of conditioned fear , 2007, Synapse.

[39]  Christopher B. Donahue,et al.  D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder , 2007, Biological Psychiatry.

[40]  S. Rauch,et al.  Recall of Fear Extinction in Humans Activates the Ventromedial Prefrontal Cortex and Hippocampus in Concert , 2007, Biological Psychiatry.

[41]  E. Hollander,et al.  Practice guideline for the treatment of patients with obsessive-compulsive disorder. , 2007, The American journal of psychiatry.

[42]  G. Quirk,et al.  Consolidation of Fear Extinction Requires NMDA Receptor-Dependent Bursting in the Ventromedial Prefrontal Cortex , 2007, Neuron.

[43]  S. Rauch,et al.  Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. , 2006, Learning & memory.

[44]  D. Charney,et al.  Neurobiology of anxiety disorders and implications for treatment. , 2006, The Mount Sinai journal of medicine, New York.

[45]  Nikolaus Weiskopf,et al.  Context-Dependent Human Extinction Memory Is Mediated by a Ventromedial Prefrontal and Hippocampal Network , 2006, The Journal of Neuroscience.

[46]  Nikolai Malykhin,et al.  Measurement of brain glutamate and glutamine by spectrally‐selective refocusing at 3 tesla , 2006, Magnetic resonance in medicine.

[47]  Bruce Fischl,et al.  Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Joseph E LeDoux,et al.  Extinction Learning in Humans Role of the Amygdala and vmPFC , 2004, Neuron.

[49]  D. Rosenberg,et al.  Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[50]  Johannes Bernarding,et al.  Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES , 2004, Magnetic resonance in medicine.

[51]  Jürgen Gallinat,et al.  Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla , 2004, NeuroImage.

[52]  G. Quirk,et al.  Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. , 2004, Behavioral neuroscience.

[53]  S. Nelson,et al.  Measurement of brain glutamate using TE‐averaged PRESS at 3T , 2004, Magnetic resonance in medicine.

[54]  Joseph E LeDoux,et al.  Ventral medial prefrontal cortex and emotional perseveration: the memory for prior extinction training , 2003, Behavioural Brain Research.

[55]  D. Paré,et al.  Stimulation of Medial Prefrontal Cortex Decreases the Responsiveness of Central Amygdala Output Neurons , 2003, The Journal of Neuroscience.

[56]  B. Platt,et al.  Glutamate receptor function in learning and memory , 2003, Behavioural Brain Research.

[57]  Michael Davis,et al.  Behavioral and Neural Analysis of Extinction , 2002, Neuron.

[58]  G. Quirk,et al.  Neurons in medial prefrontal cortex signal memory for fear extinction , 2002, Nature.

[59]  E. Hollander,et al.  Treatment non-response in OCD: methodological issues and operational definitions. , 2002, The international journal of neuropsychopharmacology.

[60]  S. Provencher.  Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[61]  G. Quirk,et al.  The Role of Ventromedial Prefrontal Cortex in the Recovery of Extinguished Fear , 2000, The Journal of Neuroscience.

[62]  Milan Hájek,et al.  Application of LCModel for quality control and quantitative in vivo1H MR spectroscopy by short echo time STEAM sequence , 2000, Magnetic Resonance Materials in Physics, Biology and Medicine.

[63]  M. Kozak,et al.  Mastery of Obsessive-Compulsive Disorder: A Cognitive-Behavioral Approach Therapist Guide , 1997, Journal of Cognitive Psychotherapy.

[64]  N. Cliff.  Answering Ordinal Questions with Ordinal Data Using Ordinal Statistics. , 1996, Multivariate behavioral research.

[65]  Joseph E LeDoux,et al.  Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. , 1995, Behavioral neuroscience.

[66]  T. Bliss,et al.  Long-term potentiation and glutamate release in the dentate gyrus: links to spatial learning , 1995, Behavioural Brain Research.

[67]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[68]  Joseph E. LeDoux,et al.  Extinction of emotional learning: Contribution of medial prefrontal cortex , 1993, Neuroscience Letters.

[69]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[70]  Jasper A. J. Smits,et al.  d-Cycloserine Augmentation of Cognitive Behavioral Therapy for Anxiety Disorders: an Update , 2014, Current Psychiatry Reports.

[71]  G. Quirk,et al.  Fear extinction as a model for translational neuroscience: ten years of progress. , 2012, Annual review of psychology.

[72]  Michael Davis,et al.  Glutamate Receptors in Extinction and Extinction-Based Therapies for Psychiatric Illness , 2011, Neuropsychopharmacology.

[73]  S. Peng,et al.  Glutamate receptors and signal transduction in learning and memory , 2010, Molecular Biology Reports.

[74]  J. Ballenger.  D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder , 2009 .

[75]  R. Malenka,et al.  Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms , 2008, Neuropsychopharmacology.

[76]  G. Quirk,et al.  Neural Mechanisms of Extinction Learning and Retrieval , 2008, Neuropsychopharmacology.

[77]  W. Mcentee,et al.  Glutamate: its role in learning, memory, and the aging brain , 2005, Psychopharmacology.

[78]  Stephen Maren.  Neurobiology of Pavlovian fear conditioning. , 2001, Annual review of neuroscience.

[79]  J. Bobes.  A Spanish validation study of the mini international neuropsychiatric interview , 1998, European Psychiatry.

[80]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .